Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects

8 Jul 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV-related health complications and treatments
Share to HIV Research and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28690189
DOI: 10.1016/j.ejphar.2017.07.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efavirenz: What is known about the cellular mechanisms responsible for its adverse effectsPMID 28690189Read ↗

In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common AntiretroviralsSemantic proximity Read ↗

Efavirenz and the CNS: what we already know and questions that need to be answered.Semantic proximity Read ↗

PharmGKB summary: Efavirenz pathway, pharmacokinetics.Semantic proximity Read ↗

Clinical impact of patient population differences and genomic variation in efavirenz therapySemantic proximity Read ↗

Cellular and Clinical Pharmacology of FludarabineSemantic proximity Read ↗

Efavirenz.Semantic proximity Read ↗

Efavirenz – Still First-line King?Semantic proximity Read ↗

Induction of Multiple Drug Transporters by EfavirenzSemantic proximity Read ↗

Tipranavir.Semantic proximity Read ↗

Efavirenz in the therapy of HIV infectionSemantic proximity Read ↗

Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?Semantic proximity Read ↗

The non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.